Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT07080034 · RECRUITING
Trial details
- NCT number
- NCT07080034
- Sponsor
- Biocad
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-14
- Primary completion
- 2027-01-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.